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Background and Purpose: Migraine is a genetically heterogeneous disorder that is frequently associated with a 
familial history, and mitochondrial dysfunction has been suggested to be associated with its pathogenesis. We 
screened and scanned mitochondrial gene polymorphisms to determine the significance of mitochondrial DNA 
mutations in Korean migraineurs.
Methods: One hundred and sixty-four migraineurs aged 33.9±11.7 years (mean±SD range 12 to 65 years) were 
studied. Clinical data of the familial history were obtained, and blood samples were collected for DNA purification. 
An A-to-G substitution at mitochondrial DNA (mtDNA) position 11,084 (A11084G) was determined by a polymerase 
chain reaction (PCR) with BsmI restriction. In addition, new single-nucleotide polymorphism (SNP) sites in the 
mitochondrial genome were scanned for using PCR and direct sequencing.
Results: Ninety-eight migraine patients (59.8%) had a maternal familial history. The A11084G polymorphism, 
which was previously reported in 25% of Japanese migraineurs, was not evident in our Korean migraine patients. 
However, scanning of new SNP sites in mtDNA revealed six candidate SNPs whose incidences were higher in 
migraine patients than in normal subjects.
Conclusion: Our study found no association between the A11084G polymorphism in mitochondrial DNA and 
migraine in Koreans. However, we found potential new mitochondrial SNP sites in Korean migraineurs, which 
warrant further investigation.
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INTRODUCTION
Migraine headache is a genetically heterogeneous 
disorder that is frequently associated with a familial 
history.
1 Mitochondrial dysfunction may play a role in 
migraine pathogenesis, as proposed by the “mitochondrial 
hypothesis”.
2,3 Molecular genetic studies in migraine 
patients have focused on mitochondrial DNA (mtDNA) 
mutations that are strongly implicated in mitochondrial 
encephalopathies, including MELAS (mitochondrial 
myopathy, encephalopathy, lactic acidosis, and stroke- 
like episodes) mutations (A3243G and T3271C), the 
MERRF mutation (G8344A), the Kearns-Sayre syndrome Journal of Clinical Neurology: Vol. 3, No. 3, 2007
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common 4977-bp deletion, and the G3460A, T4160C, 
and G11778A LHON mutations.
4 However, most of the 
studies that have searched single-nucleotide polymor-
phisms (SNPs) or mutations in mitochondrial genomes 
have failed to find any candidate mutation for migraine.
5
One study obtained apparently positive findings in a 
Japanese population. Shimomura et al. found an A-to-G 
substitution at mtDNA position 11,084 (A11084G) in 
25% (13 out of 53) of Japanese migraineurs.
6 However, 
a Danish study did not detect this mutation in subjects 
with migraine nor in subjects who had never experienced 
migraine.
7 The Danish group concluded that the A11084G 
polymorphism is rare in non-Japanese migraineurs.
7 
However, there have been no reports of investigations 
undertaken to establish whether this type of substitution 
is present in other populations, especially in those that 
are ethnically similar to Japanese subjects. 
Korea and Japan are geographically close, and 
Koreans and Japanese exhibit considerable similarity in 
their ethnicities.
8,9  This relationship prompted us to 
further investigate whether the A-to-G substitution is 
also commonly observed in Korean migraineurs. We did 
not detect the A11084G polymorphism in our study 
population, which is consistent with the Danish result 
but not with the Japanese result. We therefore further 
scanned the entire mitochondrial genome to search for 
other possible candidate nucleotide polymorphic variants 
responsible for migraine disorder.
MATERIALS AND METHODS
1. Study subjects
One hundred and sixty-four migraine patients who 
met the migraine criteria of ICHD-II (International 
Classification of Headache Disorders - second edition)
10 
and who visited the headache clinic at Seoul National 
University Hospital were enrolled. In addition, 64 control 
subjects without migraine who visited the neurology 
clinic at Seoul National University Hospital for a medical 
examination or routine neurological checkup, and 
presented with no health problems, were also included 
for comparison. After obtaining informed consents, 
detailed clinical histories including family histories and 
blood samples were collected. The terms “maternal 
inheritance” and “maternal transmission” were applied 
to patient whose mothers had migraine histories.
To scan the mitochondrial polymorphism in migraine 
patients, we enrolled a further 30 normal control subjects 
without history of migraine and 10 migraineurs with a 
maternal history. Note that we restricted the study 
population to patients with a maternal history due to 
mtDNA being transmitted maternally.
2. Mutation analysis of the mitochondrial nucleotide 
A11084G polymorphism 
DNA was purified from whole blood using a DNA 
purification kit (Promega, Madison, WI). To analyze for 
the mitochondrial nucleotide A11084G polymorphism, 
mtDNA (bases 10,835 to 11,236) was amplified by the 
polymerase chain reaction (PCR) using previously 
described primers.
6 The A11084G polymorphism generates 
a BsmI restriction site. The BsmI site containing the 
PCR product (bases 13,031–13,610) was also amplified 
as a positive control. Amplified products were digested 
with 1 unit of BsmI (New England Biolabs, Beverly, 
MA), and sized on a 1% TAE agarose gel using a 
100-bp DNA ladder marker.
3. Scanning the entire mitochondrial genome
Fortypairs of primers were used to amplify the entire 
mitochondrial genome. The PCR employed 30 cycles of 
96℃ for 30 seconds, 55℃ for 1 minute, and 72℃ for 
30 seconds. PCR products (1 kb) were obtained for each 
segment, and then direct sequencing was performed. If 
a nucleotide sequence differed by more than 25% from 
the known normal sequence, it was regarded as a poly-
morphism. A polymorphic site was considered a candidate 
for migraine when its frequency was significantly higher 
in migraineurs than in normal controls. 
4. Data analysis
Data are presented as mean±SD values and number 
(percentage) values, as appropriate. Frequency data Kang Lm, et al. Mitochondrial DNA Mutations in Korean Migraineurs
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Figure 1. A11084G polymorphism of mtDNA. PCR products digested 
with BsmI were sized on a 1% TAE agarose gel with a 100-bp DNA 
ladder marker (lane 1). Lane 2 is an amplified 402-bp mtDNA en-
compassing position 11,084. Lane 4 is a 600-bp positive control 
containing the BsmI site at position 13,309–13,314. Lanes 3 and 5 are 
PCR products digested with BsmI from lanes 2 and 4, respectively. 
The patterns of the PCR products from migraineurs and control 
subjects were identical in lanes 2 and 3.
Table 1. Possible SNP sites for migraine in mitochondrial genomes. The total number indicates the number of samples with valid 
gene amplifications and sequencings. Statistical significances (p values) between groups were tested using the chi-square test
Control subjects Migraine patients
SNPs Total (n)S N P  ( n) % Total (n)S N P  ( n)% P
T152C 21 5 23.8 9 6 66.7 0.026
G875T 17 1 5.9 9 3 33.3 0.065
G7599A 22 1 4.5 9 2 22.2 0.131
C8793T 21 1 4.8 7 2 28.6 0.078
T14667C 24 7 29.2 9 4 44.4 0.407
A15873G 25 1 4.0 7 2 28.6 0.049
between normal controls and migraineurs were compared 
using Pearson’s chi-square test. SPSS (version 11.0 for 
Windows) was used for statistical analyses, with p 
values below 0.05 considered indicative of statistical 
significance.
RESULTS
1. Patterns of familial history
The 164 patients with migraine comprised 123 women 
and 41 men aged 33.9±11.7 years (range 12 to 65 
years). Family histories were present in 131 (79.9%) 
of the migraineurs: 98 (59.8%) in the mother, 11 (6.7%) 
in the father, and 22 (13.4%) in siblings and with no 
history of maternal or paternal transmission. 
2. Mutation analysis of the mitochondrial nucleotide 
A11084G polymorphism
The 402-bp fragments determining the A11084G 
polymorphism were amplified and then cleaved by BsmI 
with a positive restriction control, since the A11084G 
polymorphism generates a BsmI restriction site. None 
of the 164 migraine patients showed evidence of the 
A11084G polymorphism, whereas all of the positive 
control samples were cleaved by BsmI (Fig. 1). This 
mutation was also not detected in the 64 normal control 
subjects.
3. Scanning the entire mitochondrial genome
We further scanned SNP sites of the mitochondrial 
genome from normal subjects (n=30) and migraine 
patients with maternal inheritance (n=10). Previous 
studies showed that human mtDNA comprises 16,553 bp 
and more than 600 polymorphic sites.
11,12 I n  t h i s  s t u d y 
we identified 75 SNP sites in the 40 subjects, of which 
6 exhibited a higher incidence in migraine patients than 
in control subjects (Table 1). T152C was present in 
66.7% of the migraineurs compared to 23.8% of the Journal of Clinical Neurology: Vol. 3, No. 3, 2007
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Figure 2. Representative sequencing results of each mtDNA SNP that is possibly related to 
migraine. Arrows indicate the SNP sites.
normal subjects (p=0.026). The SNPs G875T (normal：
migraineurs = 5.9%：33.3%), G7599A (4.5%：22.2%), 
C8793T (4.8%：28.6%), T14667C (29.2%：44.4%), and 
A15873G (4.0%：28.6%) were also frequently detected 
in migraineurs, although the difference relative to 
controls was not statistically significant (p>0.05). Known 
mitochondrial mutation sites for mitochondrial dis-
order such as A3243G and T3271C for MELAS, and 
A8344G and T8356C for MERRF were not detected 
in either normal or patients with migraine. 
DISCUSSION
In this study evaluated the association between mito-
chondrial genes and migraine. The reported A11084G 
polymorphism in mtDNA in Japanese migraineurs was 
not observed in our Korean migraineurs, despite the 
close ethnicity between Japanese and Koreans. However, 
our negative result is consistent with that found in a 
Danish study.
7 Although searches for mitochondrial 
SNPs in migraine appear to focus on the A11084G 
polymorphism, this is not supported by either our 
results or those from the Danish study.
The coding site for A11084G is the ND4 subunit of 
respiratory complex I, and the nucleotide substitution 
from A to G results in an amino acid change from 
threonine to alanine.
13 The Japanese study found that 
25% of their patients had the mutation, which was 
absent in 39 normal controls and 60 patients with 
tension-type headache.
6 However, a study of 60 Danish 
migraineurs found no evidence of this mutation, sugges-
ting the presence of ethnic differences.
7  Subsequent 
studies have found incidences of the A11084G poly-
morphism of 14% (15/105)
13 and 7.3% (35/483) in 
normal Japanese populations.
14 Genetically distingui-
shing between disease-causing mutations and benign 
polymorphisms can be difficult due to the nonavail-
ability of standard criteria.
15 In addition, the prevalence 
of the target gene mutation in the patients under 
investigation should be known before calculating the 
required sample size for the healthy control subjects.
15 
Accordingly, the search for mtDNA SNPs in migraine 
needs to be reproduced in large series of studies. 
Nevertheless, our results suggest that the etiology of 
migraine in Koreans cannot be explained by the 
presence of the mtDNA mutation at position 11,084, and 
that this mutation is rare in non-Japanese populations. 
Nevertheless, the genetic influence in migraine has 
long been discussed.
1,16 In a twins study, the concor-
dance rate of migraine was 50% in monozygotic twins 
but 14% in dizygotic twins, even though they were Kang Lm, et al. Mitochondrial DNA Mutations in Korean Migraineurs
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raised separately.
17 The P/Q-type Ca
2+-channel gene 
(CACNA1A) for familial hemiplegic migraine type 1,
18–20 
ATP1A2 or Na,K-ATPase for FHM II or III, the 
dopamine receptor,
21–23 and the calcitonin-gene-related 
peptide
24  have been described as being responsible for 
the pathogenesis of migraine. The maternal history in 
migraine patients, whose prevalence was also high in 
our study, supports the mitochondrial hypothesis of 
migraine, and several mitochondrial diseases including 
MELAS are associated with a high incidence of migraine.
3 
Studies employing magnetic resonance spectroscopy have 
revealed that mitochondrial dysfunction is present in 
patients with migraine, supporting the mitochondrial 
involvement in migraine pathophysiology.
25
Accordingly, we further searched other possible can-
didates for mitochondrial polymorphic sites that might 
be account for migraine disorders. The coding proteins 
of T152C, G875T, G7599A, C8793T, T14667C, and 
A15873G are HVS2 (hypervariable segment 2), 12S 
ribosomal RNA, cytochrome c oxidase subunit II, 
ATP synthetase F0 subunit 6, NADH dehydrogenase 
subunit 6, and cytochrome b, respectively. Among 
these, ATP synthetase, NADH dehydrogenase, and 
cytochrome b/c might be involved in electron trans-
port or energy generation, and dysfunction in these 
systems could underlie the pathogenicity of migraine. 
The limitations of our study include the small 
number of patients, and hence the newly found poly-
morphic sites need to be further confirmed in studies 
with larger populations and including other types of 
headache disorders. Moreover, because we conducted 
our study in a tertiary general hospital, the enrolled 
subjects are not representative of the general migraine 
population, and selection bias might have been present. 
Accordingly, future studies are warranted that are not 
subject to these limitations.
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